Its active ingredient, Semaglutide, reduces appetite and slows the rate at which food leaves the stomach, resulting in lower calorie intake and gradual weight reduction over time
A few clients may also experience tipsiness or weakness, especially during the first few weeks
Coverage requires that the drug isn't classified as self-administered under Medicare policy, the injection occurs in an office setting billed by the physician, and the claim includes the correct ICD-10 code, J-code, and NDC
Its worth noting that occasional supply chain issues may make Rybelsus hard to get
Incretin mimetics , also known as GLP-1 receptor agonists , are medications that mimic the action of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone